Novo Nordisk (NOVOB DC) CEO sees 15mln patient opportunities in Medicare coverage for obesity drugs
Importance
Level 1
#NOVO NORDISK A/S#NOVOB.DC#EU SESSION#US SESSION#EUROPEAN EQUITIES
© 2026 Newsquawk. All rights reserved.
© 2026 Newsquawk. All rights reserved.